Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) Network
Shikha Wadhwani(Rush University Medical Center), Myda Khalid(Indiana University Health), Aftab S. Chishti(University of Kentucky), Michelle Hladunewich(Sunnybrook Health Science Centre), Amy K. Mottl(Duke Children's Hospital & Health Center), Isa Ashoor(Louisiana State University), Michelle N. Rheault(Columbia University Irving Medical Center), Bruce Robinson(University of Michigan), Eman Abdelghani(The Ohio State University), C. John Sperati(Johns Hopkins University), Laura H. Mariani(University of Michigan), Abigail R. Smith(Arbor Research Collaborative for Health), Sarah Mansfield(Arbor Research Collaborative for Health), Siddharth Madapoosi(Georgetown University), Amira Al‐Uzri(Oregon Health & Science University), Chia-shi Wang(Emory University), Donald J. Weaver(Levine Children's Hospital), Sharon Bartosh(University of Wisconsin–Madison), Salim S. Hayek(Rush University Medical Center), David T. Selewski, Tarak Srivastava, Bryce A. Kerlin(Nationwide Children's Hospital), Craig S. Wong(University of New Mexico), Michelle M. O’Shaughnessy(Ollscoil na Gaillimhe – University of Galway)
Cited by 1
Related Papers
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
|Kidney International|2017|1.2k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study
|The Lancet Child & Adolescent Health|2017|722
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555